Corcept Therapeutics Inc

21 de set. de 2026, 20:06 UTC

Corcept Therapeutics Inc is advancing, maintaining significant gains since Friday's close, despite earlier pulling back from a session high.

18 de set. de 2026, 20:02 UTC

Shares of Corcept Therapeutics fell sharply despite a positive CHMP opinion on relacorilant for ovarian cancer and a reiterated Buy rating from HC Wainwright.

17 de set. de 2026, 20:01 UTC

Corcept Therapeutics shares are rising, supported by record revenue and net income growth for Q2 2026, along with an increased revenue guidance of up to $1.2 billion.

15 de set. de 2026, 20:07 UTC

Corcept Therapeutics Inc is trading lower amid a broader market decline, influenced by a significant drop in the NY Empire State Manufacturing Index.

14 de set. de 2026, 20:02 UTC

Corcept Therapeutics Inc shares are lower today amid broader market concerns over rising crude oil prices and inflation ahead of the Federal Reserve's interest rate decision.

11 de set. de 2026, 20:08 UTC

Corcept Therapeutics Inc shares are lower today, reflecting broader market trends amid volatility and recent inflation data showing a monthly increase of 0.4%.

10 de set. de 2026, 19:21 UTC

Corcept Therapeutics Inc shares are lower amid broader market declines and rising Treasury yields, with no specific company news identified.

8 de set. de 2026, 20:07 UTC

Corcept Therapeutics Inc shares are higher today, recovering from an early decline. The stock peaked midday but remains below the 20-day moving average.

2 de set. de 2026, 20:08 UTC

Corcept Therapeutics Inc. shares are lower today, breaking a recent trend of gains. The broader market is impacted by a weak ADP employment report.

1 de set. de 2026, 20:08 UTC

Corcept Therapeutics Inc shares are lower amid broader market declines driven by rising oil prices and increasing inflation concerns ahead of the Federal Reserve meeting.

28 de ago. de 2026, 20:01 UTC

Corcept Therapeutics Inc shares are lower, continuing a four-day decline amid notable volatility and unusually high market volume. No specific news was identified.

27 de ago. de 2026, 23:42 UTC

Corcept Therapeutics Inc is higher in after-market trading, recovering from earlier lows. Economic data showing a decline in jobless claims may support market sentiment.

26 de ago. de 2026, 19:51 UTC

Corcept Therapeutics Inc shares are lower today, reaching a session low and marking a decline since Tuesday's close, with high trading volume noted.

25 de ago. de 2026, 23:06 UTC

Corcept Therapeutics Inc shares are lower in after-market hours, reflecting a decline since Tuesday's close amid falling crude oil prices and easing geopolitical concerns.

24 de ago. de 2026, 19:36 UTC

Corcept Therapeutics shares are lower despite Zacks raising Q3 2026 EPS estimate to $0.34. The company reported Q2 earnings of $0.36 per share.

21 de ago. de 2026, 20:01 UTC

Corcept Therapeutics Inc is higher today, supported by strong sector performance and increased trading volume amid a positive growth outlook and upcoming FDA decision on Relacorilant.

20 de ago. de 2026, 23:41 UTC

Corcept Therapeutics Inc. shares are trading roughly flat in after-market hours. The asset remains above its 20-day moving average.

13 de ago. de 2026, 19:46 UTC

Corcept Therapeutics Inc is declining today, with no specific news identified. The stock peaked earlier but has since retraced from that high.

12 de ago. de 2026, 19:16 UTC

Corcept Therapeutics Inc shares are higher today amid a positive trend in U.S. stocks, despite geopolitical tensions and rising crude oil prices.

11 de ago. de 2026, 20:06 UTC

Corcept Therapeutics Inc. shares are lower today, having declined steadily after reaching a session high earlier. The stock remains above its 20-day moving average.

10 de ago. de 2026, 19:16 UTC

Corcept Therapeutics Inc shares are higher today, recovering from an early drop despite a broader market decline amid labor market concerns.

7 de ago. de 2026, 21:01 UTC

Corcept Therapeutics Inc shares are lower in after-market trading, declining despite being above its 20-day moving average and near the upper end of its one-month range.

5 de ago. de 2026, 19:56 UTC

Corcept Therapeutics Inc's shares are higher today, reflecting a generally positive market environment. The stock remains significantly above its 20-day moving average.

4 de ago. de 2026, 19:16 UTC

Corcept Therapeutics Inc shares are lower today, continuing a decline seen over the past three trading days. No specific news was identified for the drop.

3 de ago. de 2026, 20:02 UTC

Corcept Therapeutics Inc shares are lower today amid a decline in the Pharmaceuticals sub-sector, with unusually high trading volume noted.

31 de jul. de 2026, 22:26 UTC

Corcept Therapeutics shares are higher in after-market hours, peaking shortly after Friday's close despite no specific news to explain the movement.

30 de jul. de 2026, 23:11 UTC

Corcept Therapeutics shares traded lower in after-market hours, reflecting broader market uncertainty following the Federal Reserve's interest rate decision.

29 de jul. de 2026, 23:41 UTC

Corcept Therapeutics shares are trading higher in after-market hours following strong second-quarter results, with revenue of $256.1 million and raised full-year guidance.

28 de jul. de 2026, 19:46 UTC

Corcept Therapeutics shares are higher ahead of Q2 earnings tomorrow, with analysts expecting revenue growth to slow to 8.4% year-on-year.

27 de jul. de 2026, 23:46 UTC

Shares of Corcept Therapeutics Inc declined in after-hours trading, dipping to a low shortly after the market reopened. No specific news was identified.